New cream could shield transplant patients from skin cancer
NCT ID NCT05699603
Summary
This study is testing whether a combination skin cream can prevent skin cancer in people who have received an organ transplant. Organ transplant recipients take medications that weaken their immune system, which puts them at very high risk for developing skin cancer. Researchers are applying a cream containing two medications (calcipotriene and 5-fluorouracil) to pre-cancerous skin spots to see if it can stop them from turning into cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
University of Arizona Cancer Center - Prevention Research Clinic
Tucson, Arizona, 85719, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.